Calquence capsules pass Real-World safety check in CLL patients

NCT ID NCT05665374

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at the safety of Calquence (acalabrutinib) capsules in 67 people with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma. Researchers tracked side effects like infections and bone marrow problems during everyday use. The goal was to understand how safe the drug is outside of controlled clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Calquence (acalabrutinib) capsules 100 mg
What this could lead to
If successful, this study could confirm that Calquence is safe and manageable for people with untreated CLL in everyday medical practice.
What could go wrong
This is a small, completed safety study, not a large trial testing how well the drug works. Side effects like infections or bone marrow problems may still occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKAEMIA (INCLUDING SMALL LYMPHOCYTIC LYMPHOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    Aichi, Japan

  • Research Site

    Chiba, Japan

  • Research Site

    Fukuoka, Japan

  • Research Site

    Hyōgo, Japan

  • Research Site

    Kanagawa, Japan

  • Research Site

    Kyoto, Japan

  • Research Site

    Miyazaki, Japan

  • Research Site

    Nagano, Japan

  • Research Site

    Nara, Japan

  • Research Site

    Okayama, Japan

  • Research Site

    Osaka, Japan

  • Research Site

    Saitama, Japan

  • Research Site

    Shizuoka, Japan

  • Research Site

    Tokyo, Japan

  • Research Site

    Yamanashi, Japan